Recruiting studies: Nonsegmental Vitiligo

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase 2 · 70 location(s) · Takeda · NCT07108283 A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vit
Phase 3 · 79 location(s) · Incyte Corporation · NCT06804811 A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Phase 3 · 98 location(s) · Incyte Corporation · NCT06548360 Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo
Phase 2 · 1 location(s) · Hudson Biotech · NCT07437560 Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Phase 2 · 6 location(s) · Elixiron Immunotherapeutics (Hong Kong) Ltd. · NCT07223229

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.